Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion type Assertion NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_head.
- NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion description "[RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_provenance.
- NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion evidence source_evidence_literature NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_provenance.
- NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion SIO_000772 18202228 NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_provenance.
- NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion wasDerivedFrom befree-20150227 NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_provenance.
- NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_assertion wasGeneratedBy ECO_0000203 NP219089.RAv3bKwC52suBh3p-tcqJyurItMNbGcdG3sMJe1TxLp2w130_provenance.